Alzheimer’s patients are getting a second drug that fights the memory-robbing symptoms of the fatal brain disease - and may be taken by many more patients because it causes fewer side effects.
The drug Aricept, created by Japan’s Eisai Co., won Food and Drug Administration approval late Monday. Pfizer Inc., which will sell the drug here, said it will be on pharmacy shelves in several weeks.
Aricept “provides another choice” for patients who cannot take Cognex, the only other Alzheimer’s medication sold, said Dr. Zhaven Khachaturian of the Alzheimer’s Association’s Reagan Research Institute.
Some 4 million Americans suffer from Alzheimer’s disease, which has no known cause or cure.